These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 5392414)

  • 1. A new asparaginase-free inhibitor in guinea-pig properdin fraction active against tumour cells in vitro and in vivo.
    Oravec C; Cambelová J
    Neoplasma; 1969; 16(6):677-8. PubMed ID: 5392414
    [No Abstract]   [Full Text] [Related]  

  • 2. A new asparaginase-free inhibitor found in the guinea pig properdin fraction active against mouse tumour cells II. Interaction with Ehrlich's tumour in vitro and Gardner's lymphoma in vivo.
    Oravec C; Cambelová J
    Neoplasma; 1970; 17(2):111-23. PubMed ID: 5425388
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo and in vitro effects of the L-asparaginase fraction of guinea pig serum on the 6C3HED ascites lymphosarcoma.
    Borella L; Journey LJ; Hiramoto R
    Cancer Res; 1966 Dec; 26(12):2451-60. PubMed ID: 6012605
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of proteins and glycoproteins in tumour bearing mice treated with Aeromonas L-asparaginase.
    Benny PJ; Muraleedhara KG; Sreejith K; Jayashree G
    Indian J Biochem Biophys; 1996 Dec; 33(6):527-30. PubMed ID: 9219441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumour-inhibiting effect of properdin.
    Pfordte K; Ponsold W
    Neoplasma; 1969; 16(6):609-12. PubMed ID: 5369027
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination therapy of animal tumors with L-asparaginase and antagonists of glutamine or glutamic acid.
    Tarnowski GS; Mountain IM; Stock CC
    Cancer Res; 1970 Apr; 30(4):1118-22. PubMed ID: 5504351
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of palmitoylcarnitine on Ehrlich ascites tumor cells in vitro and in vivo].
    Thomitzek WD; Strack E
    Acta Biol Med Ger; 1966; 17(2):145-59. PubMed ID: 5983232
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental results in radiochemotherapy using L-asparaginase].
    Ringleb D; Billger J; Busch E; Haeger V; Jung A; Kratz L
    Fortschr Geb Rontgenstr Nuklearmed; 1972; ():Suppl:192-3. PubMed ID: 4341092
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae).
    Da Silva SL; Chaar Jda S; Yano T
    Eur J Pharmacol; 2009 Apr; 608(1-3):76-83. PubMed ID: 19222998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of anticancer activity of the alkaloid fraction of Alstonia scholaris (Sapthaparna) in vitro and in vivo.
    Jagetia GC; Baliga MS
    Phytother Res; 2006 Feb; 20(2):103-9. PubMed ID: 16444661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of the toxic metabolites of Bacillus subtilis-mesentericus on tumorous and normal cells in tissue culture].
    Volynets AK; Reznik SR
    Mikrobiol Zh; 1972; 34(5):637-40. PubMed ID: 4208819
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibitory effect of guinea pig serum on JTC-11 cell growth in vitro.
    Chikata E; Usui K; Nishizaki S; Koshiba K; Tabuchi K
    Acta Med Okayama (1952); 1967 Jun; 21(3):109-20. PubMed ID: 4229239
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of Hep2 and HeLa cell proliferation in vitro and EAC tumor growth in vivo by Lapemis curtus (Shaw 1802) venom.
    Karthikeyan R; Karthigayan S; Sri Balasubashini M; Somasundaram ST; Balasubramanian T
    Toxicon; 2008 Jan; 51(1):157-61. PubMed ID: 17936322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of levorin on the intracellular pool of free amino acids in Ehrlich ascites carcinoma cells].
    Gorozhankina IS; Lishnevskaia EB
    Antibiotiki; 1984 Oct; 29(10):751-5. PubMed ID: 6508250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infusion of red blood cell-loaded asparaginase in monkey. Immunologic, metabolic, and toxicologic consequences.
    Updike SJ; Wakamiya RT
    J Lab Clin Med; 1983 May; 101(5):679-91. PubMed ID: 6187874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On a new antibiotic of streptomycetic origin active against Ehrlich's ascitic carcinoma].
    Bertelli A; Bonmassar E; Montagnani-Marelli A; Zannini E
    Arch Ital Patol Clin Tumori; 1967; 10(1):21-8. PubMed ID: 5600138
    [No Abstract]   [Full Text] [Related]  

  • 17. Properdin system in a tumorous disease.
    ORAVEC C
    Acta Unio Int Contra Cancrum; 1963; 19():139-41. PubMed ID: 13940265
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental studies on guanosine 3',5'-cyclic monophosphate levels and airway responsiveness of the novel phosphodiesterase type 5 inhibitor SR 265579 in guinea-pigs.
    Kapui Z; Schaeffer P; Mikus EG; Boronkay E; Gyürky J; Herbert JM; Pascal M
    Arzneimittelforschung; 1999 Aug; 49(8):685-93. PubMed ID: 10483515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygen cytotoxicity in tumour cells.
    Bozzi A; Mavelli I; Mondovi B; Strom R; Rotilio G
    Bull Eur Physiopathol Respir; 1981; 17 Suppl():267-71. PubMed ID: 7248576
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative studies of clinically equivalent doses of various cytostatic agents on the mouse Ehrlich ascites carcinoma and rat Walker carcinosarcoma 256 in vivo and in cell culture (in vitro)].
    Matthias M; Tanneberger S; Gummel H
    Arch Geschwulstforsch; 1970; 36(3):240-6. PubMed ID: 5498278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.